# A Study of Dalteparin Prophylaxis in High-Risk Ambulatory Cancer Patients

> **NCT00876915** · PHASE3 · TERMINATED · sponsor: **University of Rochester** · enrollment: 218 (actual)

## Conditions studied

- Venous Thromboembolism
- Pulmonary Embolism

## Interventions

- **DRUG:** dalteparin injection

## Key facts

- **NCT ID:** NCT00876915
- **Lead sponsor:** University of Rochester
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2009-07
- **Primary completion:** 2014-07
- **Final completion:** 2014-12
- **Target enrollment:** 218 (ACTUAL)
- **Why stopped:** slow enrollment and lack of continuing funds
- **Last updated:** 2015-11-24

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00876915

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00876915, "A Study of Dalteparin Prophylaxis in High-Risk Ambulatory Cancer Patients". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00876915. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*